Coronary Artery Disease Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

Which drivers are expected to have the greatest impact on the over the coronary artery disease market's growth?
The increasing incidents of coronary artery disease are anticipated to stimulate the expansion of the coronary artery disease market in the upcoming years. Coronary artery disease (CAD) is identified by the constriction or obstruction of the coronary arteries that provide blood to the heart muscle. Dietary changes, stress, lack of physical activity, obesity, ageing, and other factors are leading to a rise in coronary artery disease cases. Treatment for this condition includes drugs like clopidogrel, ticagrelor, warfarin, and heparin, as well as procedures such as coronary artery bypass grafting, angioplasty, and stenting. For example, statistics from the Centre of Disease Control and Prevention, an agency within the U.S. Department of Health and Human Services, revealed that in May 2024, coronary heart disease (CHD) was the major type of heart disease, with 371,506 recorded deaths in 2022. Approximately 5% of adults over 20 years of age (1 in 20) were diagnosed with coronary artery disease (CAD) in 2022. Moreover, approximately 1 in 5 cardiovascular disease (CVD) deaths in 2022 were recorded in adults below 65 years old. Therefore, the growth in occurrences of coronary artery disease is predicted to positively impact the coronary artery disease market in the forecast period.

Get Your Coronary Artery Disease Market Report Here:
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

What is the future CAGR of the coronary artery disease market, and how will it impact industry expansion?
Over the past few years, the market size for coronary artery disease has seen significant growth. It is projected to expand from $29.15 billion in 2024 to $31.97 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. This substantial growth during the historic period can be linked to factors such as an increase in cases of coronary artery disease, advancement in minimally invasive surgical procedures, rise in sedentary lifestyle habits, an aging population, prevalence of coronary artery disease and the development of pharmacological treatments.

The market size for coronary artery disease is anticipated to experience swift expansion in the coming years. The projection is that it will increase to $48.48 billion in 2029 with a compound annual growth rate of 11.0%. Contributing factors to this growth during the forecasted period include lifestyle changes, an emphasis on telemedicine and distant monitoring, broadening of interventional cardiology procedures, a transition towards value-based healthcare schemes, and the advancement of new drug therapies. Major trends during this forecast period encompass the progress of gene therapies, use of artificial intelligence in diagnosis, concentration on mental health in CAD management, surge in home-based health care facilities, and the utilization of remote cardiac rehabilitation.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

What trends are poised to drive the future success of the coronary artery disease market?
Major players in the coronary artery disease industry are prioritizing the enhancement of advanced technology, such as AI-based blood tests, to maintain a strategic advantage in the market. These AI-based blood tests utilize artificial intelligence (AI) algorithms to analyze and interpret blood-related information. As an example, Cardio Diagnostics Holdings, a US firm specializing in AI-based integrated genetic-epigenetic engine creation, in February 2023, introduced PrecisionCHD. This combined genetic and epigenetic blood test is tailored for early coronary heart disease recognition. PrecisionCHD demonstrates over 75% sensitivity towards the diagnosis of coronary heart disease in both genders. The test uses a machine-learning model that processes billions of genetic and epigenomic data points, incorporating epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.

Which key market segments comprise the coronary artery disease market and drive its revenue growth?
The coronary artery disease market covered in this report is segmented -

1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments
2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors, Other Medications
2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery, Other Surgical Interventions
3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies
4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12052

What regions are at the forefront of coronary artery disease market expansion?
North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the coronary artery disease market?
Major companies operating in the coronary artery disease market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

What Is Covered In The Coronary Artery Disease Global Market Report?

• Market Size Forecast: Examine the coronary artery disease market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the coronary artery disease market for a structured understanding.
• Key Players Overview: Analyze major players in the coronary artery disease market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the coronary artery disease market.
• Segment Contributions: Evaluate how different segments drive overall growth in the coronary artery disease market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the coronary artery disease market.
• Industry Challenges: Identify potential risks and obstacles affecting the coronary artery disease market.
• Competitive Landscape: Review strategic developments in the coronary artery disease market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.